IL245317A0 - Ferric citrate for reducing cardiac failure in chronic kidney disease patients - Google Patents
Ferric citrate for reducing cardiac failure in chronic kidney disease patientsInfo
- Publication number
- IL245317A0 IL245317A0 IL245317A IL24531716A IL245317A0 IL 245317 A0 IL245317 A0 IL 245317A0 IL 245317 A IL245317 A IL 245317A IL 24531716 A IL24531716 A IL 24531716A IL 245317 A0 IL245317 A0 IL 245317A0
- Authority
- IL
- Israel
- Prior art keywords
- patients
- heart failure
- kidney disease
- chronic kidney
- ferric citrate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Inorganic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361899866P | 2013-11-04 | 2013-11-04 | |
| PCT/US2014/063643 WO2015066593A1 (en) | 2013-11-04 | 2014-11-03 | Ferric citrate for reducing cardiac failure in chronic kidney disease patients |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL245317A0 true IL245317A0 (en) | 2016-06-30 |
Family
ID=53005244
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL245317A IL245317A0 (en) | 2013-11-04 | 2016-04-27 | Ferric citrate for reducing cardiac failure in chronic kidney disease patients |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US20160256486A1 (OSRAM) |
| EP (2) | EP3747432A1 (OSRAM) |
| JP (3) | JP2016535780A (OSRAM) |
| KR (1) | KR102392441B1 (OSRAM) |
| CN (1) | CN105873583A (OSRAM) |
| AU (1) | AU2014341975A1 (OSRAM) |
| BR (1) | BR112016009901A8 (OSRAM) |
| CA (1) | CA2928200A1 (OSRAM) |
| EA (1) | EA201690926A1 (OSRAM) |
| HK (1) | HK1223031A1 (OSRAM) |
| IL (1) | IL245317A0 (OSRAM) |
| MX (1) | MX2016005734A (OSRAM) |
| SG (1) | SG11201603091QA (OSRAM) |
| TW (2) | TWI744215B (OSRAM) |
| WO (1) | WO2015066593A1 (OSRAM) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2563819C2 (ru) | 2009-07-21 | 2015-09-20 | Керикс Байофармасьютикалз, Инк. | Лекарственные формы цитрата железа (iii) |
| HRP20171590T1 (hr) | 2013-06-05 | 2017-12-29 | Tricida Inc. | Polimeri koji vežu protone za oralnu primjenu |
| EP3157516A4 (en) | 2014-06-22 | 2017-12-13 | Dexcel Pharma Technologies Ltd. | Pharmaceutical compositions comprising ferric citrate and methods for the production thereof |
| PL3229816T3 (pl) | 2014-12-10 | 2020-09-21 | Tricida Inc. | Polimery wiążące protony do podawania doustnego |
| EP3452028A4 (en) | 2016-05-06 | 2020-04-15 | Tricida Inc. | COMPOSITIONS AND METHOD FOR TREATING ACID-BASED DISORDERS |
| AU2018360867B2 (en) | 2017-11-03 | 2024-12-12 | Tricida, Inc. | Compositions for and method of treating acid-base disorders |
| EP3873492A1 (en) | 2018-10-29 | 2021-09-08 | Pharmacosmos Holding A/s | Treating iron deficiency with ferric carboxymaltose |
| CN114286682A (zh) * | 2019-02-09 | 2022-04-05 | 法码科思莫斯控股有限公司 | 治疗具有心血管不良事件风险的个体的铁缺乏以及用于治疗心房颤动的铁 |
| TW202313072A (zh) * | 2021-05-27 | 2023-04-01 | 美商凱立克斯生物製藥股份有限公司 | 檸檬酸鐵之兒科調配物 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE351366B (OSRAM) * | 1965-06-08 | 1972-11-27 | Teikoku Hormone Mfg Co Ltd | |
| US20050203169A1 (en) * | 2001-08-06 | 2005-09-15 | Moskowitz David W. | Methods and compositions for treating diseases associated with excesses in ACE |
| TWI335218B (en) | 2003-02-19 | 2011-01-01 | Panion & Bf Biotech Inc | Ferric organic compounds, uses thereof and methods of making same |
| US8093423B2 (en) | 2003-02-19 | 2012-01-10 | Globoasia, Llc | Pharmaceutical-grade ferric organic compounds, uses thereof and method of making same |
| HUE025264T2 (en) * | 2005-08-18 | 2016-02-29 | Panion & Bf Biotech Inc | Pharmaceutical-grade ferric citrate for medical use |
| KR20080094013A (ko) * | 2006-01-30 | 2008-10-22 | 글로보아시아 엘엘씨 | 연조직의 석회화 역전, 예방, 지연 또는 안정화 방법 |
| US20090186939A1 (en) * | 2006-01-30 | 2009-07-23 | Keith Chan | Method of Treating Chronic Kidney Disease |
| RU2563819C2 (ru) * | 2009-07-21 | 2015-09-20 | Керикс Байофармасьютикалз, Инк. | Лекарственные формы цитрата железа (iii) |
| WO2012006473A1 (en) * | 2010-07-07 | 2012-01-12 | Ardelyx, Inc. | Compounds and methods for inhibiting phosphate transport |
| SG10201805177PA (en) * | 2012-06-21 | 2018-07-30 | Keryx Biopharmaceuticals Inc | Use of ferric citrate in the treatment of chronic kidney disease patients |
-
2014
- 2014-11-03 JP JP2016552432A patent/JP2016535780A/ja active Pending
- 2014-11-03 BR BR112016009901A patent/BR112016009901A8/pt not_active Application Discontinuation
- 2014-11-03 EP EP20173867.1A patent/EP3747432A1/en active Pending
- 2014-11-03 AU AU2014341975A patent/AU2014341975A1/en not_active Abandoned
- 2014-11-03 EA EA201690926A patent/EA201690926A1/ru unknown
- 2014-11-03 WO PCT/US2014/063643 patent/WO2015066593A1/en not_active Ceased
- 2014-11-03 SG SG11201603091QA patent/SG11201603091QA/en unknown
- 2014-11-03 KR KR1020167014000A patent/KR102392441B1/ko active Active
- 2014-11-03 HK HK16111332.6A patent/HK1223031A1/zh unknown
- 2014-11-03 EP EP14858106.9A patent/EP3065734A4/en not_active Ceased
- 2014-11-03 CN CN201480072217.1A patent/CN105873583A/zh active Pending
- 2014-11-03 CA CA2928200A patent/CA2928200A1/en not_active Abandoned
- 2014-11-03 US US15/031,678 patent/US20160256486A1/en not_active Abandoned
- 2014-11-04 TW TW103138244A patent/TWI744215B/zh active
- 2014-11-04 TW TW110136784A patent/TW202203910A/zh unknown
-
2015
- 2015-01-29 MX MX2016005734A patent/MX2016005734A/es unknown
-
2016
- 2016-04-27 IL IL245317A patent/IL245317A0/en unknown
-
2018
- 2018-12-11 US US16/216,772 patent/US20190307791A1/en not_active Abandoned
-
2019
- 2019-07-31 JP JP2019140640A patent/JP6828100B2/ja active Active
-
2021
- 2021-01-20 JP JP2021007091A patent/JP2021073230A/ja active Pending
-
2024
- 2024-12-31 US US19/006,830 patent/US20250360167A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| BR112016009901A8 (pt) | 2020-04-14 |
| KR20160096597A (ko) | 2016-08-16 |
| KR102392441B1 (ko) | 2022-05-02 |
| JP2016535780A (ja) | 2016-11-17 |
| MX2016005734A (es) | 2016-11-08 |
| US20160256486A1 (en) | 2016-09-08 |
| JP6828100B2 (ja) | 2021-02-10 |
| HK1223031A1 (zh) | 2017-07-21 |
| TW201609088A (zh) | 2016-03-16 |
| WO2015066593A1 (en) | 2015-05-07 |
| EP3065734A4 (en) | 2017-05-17 |
| EP3065734A1 (en) | 2016-09-14 |
| CN105873583A (zh) | 2016-08-17 |
| CA2928200A1 (en) | 2015-05-07 |
| TW202203910A (zh) | 2022-02-01 |
| US20250360167A1 (en) | 2025-11-27 |
| SG11201603091QA (en) | 2016-05-30 |
| AU2014341975A1 (en) | 2016-05-19 |
| TWI744215B (zh) | 2021-11-01 |
| EA201690926A1 (ru) | 2016-09-30 |
| JP2019206562A (ja) | 2019-12-05 |
| JP2021073230A (ja) | 2021-05-13 |
| EP3747432A1 (en) | 2020-12-09 |
| US20190307791A1 (en) | 2019-10-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL245317A0 (en) | Ferric citrate for reducing cardiac failure in chronic kidney disease patients | |
| CY2023027I2 (el) | Ενωσεις πυριμιδινοδιονης εναντι καρδιακων παθησεων | |
| NO2025048I1 (no) | Ferric citrate coordination complex | |
| EP3862044C0 (en) | TWO-TIP HEMODIALYSIS CATHETER | |
| DK3329951T3 (da) | Intravaskulær blodpumpe | |
| EP3362123A4 (en) | MEDICAL LUER CONNECTION | |
| BR302013004536S1 (pt) | Configuração aplicada em curativo médico | |
| EP2869866A4 (en) | Catheter pump | |
| EP2968894A4 (en) | MEDICAL CONNECTOR | |
| DK3127563T3 (da) | Pumpe, især blodpumpe | |
| BR302013004565S1 (pt) | Configuração aplicada em curativo médico | |
| EP3821931C0 (en) | ORONASAL PATIENT INTERFACE | |
| EP2922514A4 (en) | BI-RADIAL PATIENT INTERFACE | |
| BR302013006823S1 (pt) | Configuração aplicada em curativo médico | |
| BR302013006043S1 (pt) | Configuração aplicada a uma cadeira | |
| IL233089A0 (en) | Methods for improving medical therapies | |
| EP2913047A4 (en) | Pulmonary disease-specific therapeutic agent | |
| IL272222B (en) | Electrocardiogram noise reduction | |
| EP2974614A4 (en) | MIDSOLE WITH A LAYER STRUCTURE | |
| HRP20190122T1 (hr) | Protutijelo protiv adrenomedulina (adm) ili fragment protutijela protiv adm ili okosnica ne-ig protiv adm, namijenjeni reguliranju ravnoteže tekućina kod pacijenta s kroničnom ili akutnom bolešću | |
| EP2914112A4 (en) | TREATMENT OF CANCER WITH POMALIDOMIDE ON A PERSON WITH AFFECTED KIDNEY FUNCTION | |
| FR3003776B1 (fr) | Coffre a tamiser. | |
| BR302012004766S1 (pt) | Configuracao aplicada em injetor médico | |
| LT2958624T (lt) | Transplantuotų pacientų transplantanto prieš šeiminiką ligos gydymas | |
| JP2015535291A5 (OSRAM) |